In addition, association between BRCA1, [41, 45] MDR1, [48] eIF3a, [49, 50] PKM2, [51] and clinical outcomes in NSCLC treated with platinum-based regimen were also investigated. This evidence concerns the gene PKM and non-small cell lung carcinoma.